Could a common supplement protect eyes in diabetes?

NCT ID NCT07634991

Recruiting now Disease control Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

First seen Jun 12, 2026 · Last updated Jun 16, 2026 · Updated 1 time

Summary

This study tests whether N-acetyl cysteine (NAC), a safe supplement, can reduce oxidative stress and improve eye health in people with type 2 diabetes who have mild to moderate diabetic retinopathy. About 76 adults aged 18-70 will take NAC to see if it lowers damage to blood vessels in the eye. The goal is to slow or control the disease, not cure it.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY (DR) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

National Institute of Diabetes and Endocrinology.
RECRUITING

Cairo, Egypt
National Institute of Diabetes and Endocrinology.
RECRUITING

Cairo, Egypt

Contact

Conditions

Explore the condition pages connected to this study.

DIABETIC RETINOPATHY (DR)

Conditions inferred from the trial description

These were inferred from the trial's summary, not listed by the trial registrant.

DIABETIC RETINOPATHY